Mylan finalizes $465M settlement over EpiPen billing lawsuit
Thursday, August 17, 2017 - 15:32
in Mathematics & Economics
Mylan, makers of the anti-allergy injector EpiPen, finalized a $465 million settlement with the federal government over allegations it over-billed Medicaid.